<prompt> True about febuxostat:Anti-gout and Xanthine Oxidase inhibitorPurine inhibitorDose adjustment required in renal impairmentHas uricosuric action  <response>: Ref: Katzungs Pharmacology, 14th ed. pg. 662-63 Febuxostat is a non-purine inhibitor of xanthine oxidase and thereby reduces the formation of xanthine and uric acid and is useful in management of gout. It is 80 absorbed following oral administration and extensively metabolized in the liver. All of the drug and its metabolites appear in the urine although less than 5 appears as unchanged drug. Because it is highly metabolized to inactive metabolites, no dosage adjustment is necessary for patients with renal impairment. 